323 related articles for article (PubMed ID: 34580719)
21. Emerging role of exosomal long non-coding RNAs in lung cancer.
He L; Lin M; Shen J; Qi H
Mol Biol Rep; 2022 Jun; 49(6):4989-4997. PubMed ID: 35083616
[TBL] [Abstract][Full Text] [Related]
22. Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer.
Li P; Li J; Yang R; Zhang F; Wang H; Chu H; Lu Y; Dun S; Wang Y; Zang W; Du Y; Chen X; Zhao G; Zhang G
Diagn Pathol; 2015 Jun; 10():63. PubMed ID: 26055877
[TBL] [Abstract][Full Text] [Related]
23. Expression of long non-coding RNA SFTA1P and its function in non-small cell lung cancer.
Du D; Shen X; Zhang Y; Yin L; Pu Y; Liang G
Pathol Res Pract; 2020 Sep; 216(9):153049. PubMed ID: 32825934
[TBL] [Abstract][Full Text] [Related]
24. Long non‑coding RNAs as potential therapeutic targets in non‑small cell lung cancer (Review).
Tang P; Sun D; Xu W; Li H; Chen L
Int J Mol Med; 2023 Aug; 52(2):. PubMed ID: 37350412
[TBL] [Abstract][Full Text] [Related]
25. LncRNA HULC promotes non-small cell lung cancer cell proliferation and inhibits the apoptosis by up-regulating sphingosine kinase 1 (SPHK1) and its downstream PI3K/Akt pathway.
Liu L; Zhou XY; Zhang JQ; Wang GG; He J; Chen YY; Huang C; Li L; Li SQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8722-8730. PubMed ID: 30575912
[TBL] [Abstract][Full Text] [Related]
26. Upregulation of long intergenic noncoding RNA 00673 promotes tumor proliferation via LSD1 interaction and repression of NCALD in non-small-cell lung cancer.
Shi X; Ma C; Zhu Q; Yuan D; Sun M; Gu X; Wu G; Lv T; Song Y
Oncotarget; 2016 May; 7(18):25558-75. PubMed ID: 27027352
[TBL] [Abstract][Full Text] [Related]
27. Urinary Exosomal Long Noncoding RNA TERC as a Noninvasive Diagnostic and Prognostic Biomarker for Bladder Urothelial Carcinoma.
Chen C; Shang A; Sun Z; Gao Y; Huang J; Ping Y; Chang W; Gu C; Sun J; Ji P; Yuan Y; Lu R; Li D
J Immunol Res; 2022; 2022():9038808. PubMed ID: 35127956
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR data.
Chen YJ; Guo YN; Shi K; Huang HM; Huang SP; Xu WQ; Li ZY; Wei KL; Gan TQ; Chen G
Respir Res; 2019 Mar; 20(1):48. PubMed ID: 30832674
[TBL] [Abstract][Full Text] [Related]
29. A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer.
Zhou M; Guo M; He D; Wang X; Cui Y; Yang H; Hao D; Sun J
J Transl Med; 2015 Jul; 13():231. PubMed ID: 26183581
[TBL] [Abstract][Full Text] [Related]
30. LncRNA BRCAT54 inhibits the tumorigenesis of non-small cell lung cancer by binding to RPS9 to transcriptionally regulate JAK-STAT and calcium pathway genes.
Yang W; Qian Y; Gao K; Zheng W; Wu G; He Q; Chen Q; Song Y; Wang L; Wang Y; Gu P; Chen B; Zhai R
Carcinogenesis; 2021 Feb; 42(1):80-92. PubMed ID: 32459848
[TBL] [Abstract][Full Text] [Related]
31. Evaluating the expression of tumorigenic long noncoding RNAs in circulating exosomes isolated from non-small-cell lung cancer patients.
Shi Z; Huang K; Li Z; Niu Y; Jiang L
Biomark Med; 2022 Mar; 16(4):241-251. PubMed ID: 35209738
[No Abstract] [Full Text] [Related]
32. Long non-coding RNA as potential biomarkers in non-small-cell lung cancer: What do we know so far?
Osielska MA; Jagodziński PP
Biomed Pharmacother; 2018 May; 101():322-333. PubMed ID: 29499406
[TBL] [Abstract][Full Text] [Related]
33. RNA sequencing reveals the emerging role of bronchoalveolar lavage fluid exosome lncRNAs in acute lung injury.
Song M; Zhang X; Gao Y; Wan B; Wang J; Li J; Song Y; Shen X; Wang L; Huang M; Wang X
PeerJ; 2022; 10():e13159. PubMed ID: 35378935
[TBL] [Abstract][Full Text] [Related]
34. Tumor-derived exosomal lncRNA GAS5 as a biomarker for early-stage non-small-cell lung cancer diagnosis.
Li C; Lv Y; Shao C; Chen C; Zhang T; Wei Y; Fan H; Lv T; Liu H; Song Y
J Cell Physiol; 2019 Nov; 234(11):20721-20727. PubMed ID: 31032916
[TBL] [Abstract][Full Text] [Related]
35. Circulating plasma lncRNAs as novel markers of EGFR mutation status and monitors of epidermal growth factor receptor-tyrosine kinase inhibitor therapy.
Lv P; Yang S; Liu W; Qin H; Tang X; Wu F; Liu Z; Gao H; Liu X
Thorac Cancer; 2020 Jan; 11(1):29-40. PubMed ID: 31691525
[TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNAs: How to regulate the metastasis of non-small-cell lung cancer.
Fang C; Wang L; Gong C; Wu W; Yao C; Zhu S
J Cell Mol Med; 2020 Mar; 24(6):3282-3291. PubMed ID: 32048814
[TBL] [Abstract][Full Text] [Related]
37. Identification of lncRNA biomarkers in lung squamous cell carcinoma using comprehensive analysis of lncRNA mediated ceRNA network.
Li R; Yang YE; Jin J; Zhang MY; Liu X; Liu XX; Yin YH; Qu YQ
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3246-3258. PubMed ID: 31364871
[TBL] [Abstract][Full Text] [Related]
38. Analysis of lncRNA expression profiles in non-small cell lung cancers (NSCLC) and their clinical subtypes.
Yang J; Lin J; Liu T; Chen T; Pan S; Huang W; Li S
Lung Cancer; 2014 Aug; 85(2):110-5. PubMed ID: 24906504
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive analysis of dysregulated exosomal long non-coding RNA networks associated with arteriovenous malformations.
Li X; Gui Z; Han Y; Yang X; Wang Z; Zheng L; Zhang L; Wang D; Fan X; Su L
Gene; 2020 May; 738():144482. PubMed ID: 32087271
[TBL] [Abstract][Full Text] [Related]
40. Exosomal long non-coding RNA MSTRG.292666.16 is associated with osimertinib (AZD9291) resistance in non-small cell lung cancer.
Deng Q; Fang Q; Xie B; Sun H; Bao Y; Zhou S
Aging (Albany NY); 2020 May; 12(9):8001-8015. PubMed ID: 32375124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
